Sandra Beaver
CIK: 0001944884
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- May 20, 2026TNDM
TANDEM DIABETES CARE INC
Award(A)DirectRestricted Stock Unit
5.1K shares- - Nov 7, 2025TNDM
TANDEM DIABETES CARE INC
Award(A)DirectRestricted Stock Unit
20.2K shares- - May 13, 2025EOLS
Evolus, Inc.
Sale(S)Direct6.5K shares at avg. $10.02$65K - Mar 18, 2025EOLS
Evolus, Inc.
Sale(S)Direct9K shares at avg. $13.26$119K - Mar 7, 2025EOLS
Evolus, Inc.
Award(A)Direct35.7K shares- - Dec 23, 2024EOLS
Evolus, Inc.
Sale(S)Direct1.6K shares at avg. $10.85$17K - Sep 6, 2024EOLS
Evolus, Inc.
Sale(S)Direct3.3K shares at avg. $14.98$49K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 20, 2026 |  TNDM TANDEM DIABETES CARE INC | Award(A) Restricted Stock Unit | 5,110 | - | - | Direct |
| Nov 7, 2025 | TNDM TANDEM DIABETES CARE INC | Award(A) Restricted Stock Unit | 20,242 | - | - | Direct |
| May 13, 2025 |  EOLS Evolus, Inc. | Sale(S) | 6,494 | $10.02 | $65,070 | Direct |
| Mar 18, 2025 | EOLS Evolus, Inc. | Sale(S) | 8,996 | $13.26 | $119,243 | Direct |
| Mar 7, 2025 | EOLS Evolus, Inc. | Award(A) | 35,663 | - | - | Direct |
| Dec 23, 2024 | EOLS Evolus, Inc. | Sale(S) | 1,586 | $10.85 | $17,211 | Direct |
| Sep 6, 2024 | EOLS Evolus, Inc. | Sale(S) | 3,276 | $14.98 | $49,074 | Direct |
1-7 of 7 transactions
About Beaver Sandra
Beaver Sandra (SEC CIK 0001944884) files insider reports with the SEC as Director of TANDEM DIABETES CARE INC (TNDM) and Chief Financial Officer of Evolus, Inc. (EOLS).
Signal8 holds 8 ownership filings by Beaver Sandra (1 Form 3, 7 Form 4), filed between Sep 6, 2024 and May 22, 2026. Those filings report 7 transactions, from Sep 6, 2024 to May 20, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Beaver Sandra's filings is in NEWPORT BEACH, CA.
Recent filings by Beaver Sandra
- May 20, 2026: Grant or award of TNDM derivative securities (Form 4, code A).
- Nov 7, 2025: Grant or award of TNDM derivative securities (Form 4, code A).
- May 13, 2025: Open-market sale of EOLS shares (Form 4, code S).
- Mar 18, 2025: Open-market sale of EOLS shares (Form 4, code S).
- Mar 7, 2025: Grant or award of EOLS shares (Form 4, code A).
Other insiders filing for TANDEM DIABETES CARE INC (TNDM)
- TWOMEY CHRISTOPHER J, Director
- Kyrillos Jean-Claude, EVP & Chief Operating Officer
- Vosseller Leigh, EVP & CHIEF FINANCIAL OFFICER
- Sheridan John F, PRESIDENT & CEO
- Morrison Susan, EVP & Chief Admin. Officer
- Gasser Elizabeth Anne, EVP, Chief Strategy Officer